Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MedMira Inc V.MIR

Alternate Symbol(s):  MMIRF

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.


TSXV:MIR - Post by User

<< Previous
Bullboard Posts
Next >>
Post by august202013on Oct 17, 2024 4:30pm
83 Views
Post# 36270583

NOT CHOICE BUY YO HANG ON!

NOT CHOICE BUY YO HANG ON! SEE ANNOUNCEMENT MADE ON AUGUST, 13, 2024 OR 2 MONTHS + 4 DAYS FOR FULL CLINICAL TRIALS FOR MULTIPLO COMPLETE SYPHILIS ANTIBODY TEST WITH REACH NEXUS @ ST. MITCHELL'S HOSPITAL MAP - CTR FOR URBAN HEALTH SOLUTIONS IS IN PROCRESS BUT MINORITY LONG-TERM SHAREHOLDER ARE NOT PRIVY TO ANY UPDATES.

HOWEVER AS MENTIONED EARLIER PREVIOUS TEST ALREADY DONE IN ONE HOSPITAL IN BC AND I SASKATCHEWAN WERE +VE. PETEY78 FRIEND CLOWN CANNOT PROVIDE ANY UPDATES BUT UNLIKE DRUGS TESTING WHICH RUN INTO MANY PHASES THIS IS JUST A TEST KIT FOR PETE SAKE!? WE SINCERELY HOPE IT WON'T GO INTO YEARS FOR TESTING SIMILAR TO DRUGS TESTING HAVE TO UNDER GO!

ANYWAY ALSO AS MENTIONED. WE HOPE THE NEW VP OF COMMERCIAL OPERATIONS AND PETEY78 C. OWN FRIEND COULD GO DO SOME MARKETING AND BRING IN SOME SALES ASAP INSTEAD OF LAYING EGGS! 
<< Previous
Bullboard Posts
Next >>